Dr. Sullivan graduated in Medicine and Surgery from the National University of Rosario in 2005, specializing in Medical Oncology through the MIR at the Santa Creu i Sant Pau Hospital (HSCiSP, 2012) in Barcelona.
She received a post-MIR scholarship from the Ministry of Interior from HSPiSP (2012) and then a pre-doctoral scholarship from ISCiii (Rio Hortega – 2013-2015).
In 2014, he moved to Paris where he obtained a DUERTECC diploma at the Gustave Roussy University Hospital (Villejuif), followed by an ESMO scholarship (Georges Mathé Translator Scholarship), which he received in 2016.
Since January 2017, he has been working on the staff of the Medical Oncology Department of the HSCiSP. In the same year, he obtained his PhD from the Autonomous University of Barcelona.
Since 2015, he has been a member of the Board of Directors of the Spanish Lung Cancer Group (GECP). And since 2022, he has been the coordinator of the HSCiSP Committee on Neuroendocrine Tumors.
In November 2021, she joined the IOR Medical Oncology Service and is actively involved in various research projects in the Pangea Lab under the supervision of Dr. Molina.
Dr. Sullivan is involved in several clinical trials in lung cancer and neuroendocrine tumors, many of which have been presented at various international scientific meetings.
She has participated in national and international conferences and is an author and co-author of research articles published in influential journals.
She is currently a member of the Spanish Society of Medical Oncology (SEOM), GECP, European Society of Medical Oncology (ESMO), American Society of Clinical Oncology (ASCO), European Organization for Research and Treatment of Cancer (EORTC) and the Spanish Group of Neuroendocrine and Endocrine Tumors (GETNE).
Read moreDoctor's visit | price on request |
Brain tumor removal | $27926 - $42251 |
Removal of spinal cord tumor | $26786 - $37500 |
Chemotherapy for larynx cancer | $3844.11 - $6040.74 |
Experience
2002-present | Attached to the Department of Gamma Radiosurgery and Functional Neurosurgery of Ruber International Hospital.
2002-2007 | Assistant, Department of Radiation Oncology, Ruber International Hospital.
2002| Medical Affairs Manager Medical Department Janssen-Cilag, SA Madrid
Qualification
2012|Doctor of Medicine and Surgery Madrid. Department of Surgery, Autonomous University of Madrid. Spain
2001 | Specialist in Radiation Oncology at the Gregorio Marañón University Hospital in Madrid. Training completed at the Gustave-Roussy Institute in Paris in 2000.
1995 | Graduate of the Faculty of Medicine and Surgery, Complutense University of Madrid. Spain.
2016-present | Member of the Ruber International Hospital Gamma Knife Radiosurgery Team, International Gamma Knife Consortium: Led by the Pittsburgh Hospital.
1999-2000| Project Manager: "Protocol for Pamidronate Treatment of Breast Cancer Patients with Predominantly Lytic Bone Metastases"
1999 | GICOR Study: "Incidence of Anemia in Patients Receiving Radiation Therapy"
1999 | GICOR study: "Androgen deprivation protocol associated with radiation therapy for localized high-risk prostate cancer"
1997-2001|Participant (collaborator) in the research project (FIS FELLOWSHIP): "Multimodal fusion of medical images in oncology" at HGU Gregorio Marañon. Project leader: Dr. Desco Menéndez.
Teaching :
2018-present|Professor of the International Master of Radiosurgery of the Central Nervous System at the Complutense University of Madrid.
2020-present|Professor at the School of Radiosurgery of the Spanish Society of Neurosurgeons.
2017-2019|Professor of the Master of Radiosurgery and Clinical Stereotactic Radiotherapy of the Spanish Society of Radiation Oncology.
2017 - 2022| Member of the Dissertation Committee in Radiosurgery three times at the Autonomous University of Madrid and the Complutense University of Madrid.
2011-2012|Professor, International Master's Program in Advanced Technological Applications in Radiation Oncology, 3rd ed.
2001-2002|Associate Professor of Dentistry at the Alfonso X El Sabio University.
1998 - 2001|Professor of the secondary school I.E. Technical and vocational school of health K.A.M. (Radiation oncology technicians and archival technicians).
Publications
2022|Stereotactic radiosurgery of obsessive-compulsive disorders. Chapter. 25. Book: Intracranial stereotactic radiosurgery. ed. 2022. Pages: 251-256.
2022|Active monitoring and stereotactic radiosurgery provide a low risk of symptoms associated with incident frontobasal meningioma, but stereotactic radiosurgery provides better radiological control – a subanalysis of the IMPASSE trial. Cancers 2022; 14(5).1300. https://doi.org/10.3390/cancers14164047
2022|Stereotactic radiosurgery for Kuss grade IV vestibular schwannoma: a multi-institutional study. Journal of Neurosurgery. 2022 Jun 3; DOI: 10.3171/2022.4.JNS22203.
2022|Stereotactic radiosurgery for Rathke's cleft cyst: an international multicenter study. J Neurosurg 137: 1041–1046, 2022. DOI: 10.3171/2021.12.JNS212108.
2021|Surgery and radiosurgery in autism: a retrospective study on 10 patients. Stereotactic Function Neurosurgery. 2021;99(6):474–483. 15.
Presentations
2019| "Other indications in malignant tumor pathology" Cranial Radiosurgery Conference. Valencia 2019.
2018| Gamma Knife Radiosurgery: Concept, Equipment and Treatment Description I Scientific Conference on Gamma Knife Radiosurgery, Madrid, 2018
2018|Radiotherapy and protons in children. XX meeting of the SENEC Working Group on Neuro-Oncology:. Madrid.
2015| "Visualization monitoring of response and complications of brain treatment". XVIII National Congress of S.E.O.R. Valencia
2015 | Gamma Knife Radiosurgery in the Treatment of Refractory Epilepsy Associated with Nodular Heterotopia: Long-Term Safety and Efficacy. Congress of the Spanish Society of Neurology.
Communities it belongs to:
-SER, Spanish Society of Radiosurgery (she currently serves on the Board of Directors as Treasurer)
-SEOR, Spanish Society of Oncological Radiotherapy: Working Groups "Brain Tumors (NEUROONCOR)" and "Radiation Oncology Activities in the Private Sector"
-SSRI, International Society for Stereotactic Radiosurgery
- Member of the Oncology Group of the Spanish Society of Neurosurgery (SENEC).
Dr. Nuria Martínez Moreno , working in tandem with Dr. Roberto Martínez Álvarez, combines expert oncology knowledge and high-precision radiosurgery technology , providing patients with the most advanced and effective treatment in Spain.
Read moreProfessional experience:
Education:
Publications:
Dr. Ares is the author of 34 scientific articles published in peer-reviewed medical journals.
Her extensive international experience and commitment to innovative treatments make her a leading expert in proton therapy and radiation oncology.
Professional experience:
Education:
Publications:
Dr. Ares is the author of 34 scientific articles published in peer-reviewed medical journals.
Her extensive international experience and commitment to innovative treatments make her a leading expert in proton therapy and radiation oncology.
Read moreThis specialist has made significant contributions to the development of proton therapy, radiation oncology and medical physics, combining scientific research, teaching and work at the world's leading medical and research institutions.
Read moreDr. Joseba Rebollo Liceaga is a seasoned medical oncologist with a comprehensive background in oncology.
Education and Training:
Graduated in Medicine and Surgery from the University of Navarra (1985).
Completed residency in Oncology in 1987.
Specialist in Medical Oncology at the Clínica Universidad de Navarra (1991).
Professional Experience:
Head of the Oncology Department at Clínica San Miguel de Navarra (1991–2004).
Associate Physician at the University Clinic of the Faculty of Medicine, University of Navarra (1995–2002).
Adjunct Physician at the Oncology Platform, Hospital Quirónsalud Torrevieja (2004–2014).
Head of the Oncology Department at Hospital General de Villalba (2014–2019).
Currently practices as a Medical Oncology Specialist at Quirónsalud Alicante.
Certifications and Training:
Completed multiple accredited courses in Multidisciplinary Oncology between 2003 and 2006.
Research and Publications:
Authored research on electrochemotherapy and multidisciplinary treatment approaches in oncology.
Read more
Doctor of Medicine, Cum Laude, University of Navarra (1991)
Medical Degree, University of Navarra (1979–1985), Graduated with Honors
Board-Certified Specialist in Medical Oncology, via Spanish MIR system, Clínica Universidad de Navarra (1986–1989)
Advanced Fellowship in Immunotherapy, Cleveland Clinic Foundation, USA
Head of Medical Oncology (1993–2000) and Director of the Cancer Institute (2000–2002), General Hospital of Catalonia
Director of Hematopoietic Progenitor Transplant Program, General Hospital of Catalonia (1993–2002), accredited by the Catalonian Health Department
Senior Specialist in Oncology, Quirónsalud Torrevieja (since 2002)
Personalized Cancer Therapy using RNA microarrays and pharmacogenomics
Bone Marrow Transplants and High-Dose Chemotherapy
High-Dose Interleukin-2 Therapy via intravenous bolus for solid tumors
Personalized Cellular Anti-Tumor Vaccines
Hyperthermic Isolated Limb Perfusion with TNF and melphalan
Intra-arterial and Intraoperative Chemotherapy (HIPEC) for advanced cancers
Author of 120+ scientific papers and conference presentations
Active contributor to the development of novel cancer immunotherapies and drug personalization strategies
AACR – American Association for Cancer Research
ASCO – American Society of Clinical Oncology
ASH – American Society of Hematology
Read more